Purified recombinant human Chromogranin A N46 peptide with remarkable anticancer effect on human colon cancer cells

Bibliographic Information
Authors: Okasha H.; Samir S.; Nasr S.M.
Journal: Bioorganic Chemistry
Publisher: Academic Press Inc.
Publication Date: October 2021
Volume / Issue: Volume 115
Article No.: 105266
ISSN: 452068
DOI: 10.1016/j.bioorg.2021.105266
Scopus: View on Scopus
PubMed: 34449322
Document Type: Article
Authors and Affiliations
Okasha H., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Samir S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Nasr S.M., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Human Chromogranin A N46 (CGA-N46) is a weak cationic α-helical peptide with wide-spectrum antibacterial, fungal, and anticancer activities. In this study, the recombinant human CGA-N46 peptide was expressed successfully in Escherichia coli. The gene of CGA-N46 was cloned into the expression vector pET-15b without a fusion tag at the N terminus and the peptide was expressed using Isopropyl-β-D-thiogalactoside (IPTG) as an inducer. Using 8 M guanidinium HCl, inclusion bodies containing the peptide were purified and solubilized. The rhCGA-N46 peptide was purified using Q-FF anion exchange column. The cytotoxicity of the purified rhCGA-N46 peptide was investigated on WI-38 human lung normal cell line. The anticancer activity was studied on human colon cancer cell line; HCT-116 cell line. Besides, the possible involvement of rhCGA-N46 peptide in regulating apoptotic signal pathways was analyzed by detecting the expression levels of BCL2, BID, and CAS-8 in the treated cells. The results concluded that the active peptide recovery was up to 41.98%. The purified rhCGA-N46 was safe on normal cells with IC50 = 227.74 µg/ml (40.67 µM) and had an obvious anticancer effect on colon cancer cells with IC50 = 1.997 µg/ml (356.6 nM). The expression level of BCL2 was down-regulated and BID and CAS-8 were up-regulated significantly in treated HCT-116 cells compared to untreated. In conclusion, the rhCGA-N46 peptide was produced successfully in the native form with promising anti-colon cancer activity. © 2021 Elsevier Inc.
Keywords
Apoptosis; Chromogranin; Cisplatin; Colon cancer; E. coli; Peptide; Cell Line; Cell Proliferation; Cell Survival; Chromogranin A; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Peptides; Recombinant Proteins; Structure-Activity Relationship; antineoplastic agent; caspase 8; isopropyl thiogalactoside; protein bcl 2; protein Bid; recombinant human chromogranin A N46 peptide; unclassified drug; recombinant protein; antineoplastic activity; Article; cell inclusion; controlled study; cytotoxicity; down regulation; Escherichia coli; expression vector; HCT 116 cell line; human; human cell; IC50; molecular cloning; nonhuman; polyacrylamide gel electrophoresis; protein expression level; selectivity index; upregulation; WI-38 cell line; chemical structure; chemistry; colon tumor; dose response; drug effect; drug screening; metabolism; pathology; structure activity relation
Citation Information
Scopus Citations: 17
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
